This episode currently has no reviews.
Submit ReviewZachary Sweeney is on a mission to discover important drugs to cure and manage some of the biggest present and future threats to our health. His biotech startup has already attracted almost $100M in capital and some great talent to further this mission. The venture, Interline Therapeutics has attracted the interest of top-tier investors like Foresite Capital and ARCH Venture Partners.
This episode currently has no reviews.
Submit ReviewThis episode could use a review! Have anything to say about it? Share your thoughts using the button below.
Submit Review